HVPCI reports positive swing to patient confidence
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
December, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
November 24, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
Building a modern data infrastructure within today’s healthcare enterprise is challenging on many...
October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its...
The “acceleration of digital health transformation” means many things to many people, but through...
“COVID-19 has impacted nearly every organization—from enterprise to startup—and their strategies...
September 17, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its...
September 3, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its...
Technology has impacted all aspects of modern life, making many processes more efficient and widely...
August 21, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity...
Few areas of medicine have captured public interest over the past two years quite like glucagon-like peptide-1 (GLP-1) receptor agonists. Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and...